Search research articles
Contact Us
Filters
Showing results (51-60 of 64) with videos related to
Page
of 7
Sort By:
Journal of Clinical Apheresis
|
May 28, 2021
Race/ethnicity and underlying disease influences hematopoietic stem/progenitor cell mobilization response: A single center experience
Chukwuemeka Uzoka, Li C Liu, Youngmin Park, et al.
Academic Radiology
|
May 3, 2022
A Clinically Optimal Protocol for the Imaging of Enteric Tubes: On the Basis of Radiologist Interpreted Diagnostic Utility and Radiation Dose Reduction
Wesley J Klejch, Emily L Marshall, Kayla F Blunt, et al.
Molecular Medicine (Cambridge, Mass.)
|
May 19, 2026
Gdf15 expression in thermogenic adipocytes regulates diet-induced weight gain in a sex-dependent manner
Jayashree Jena, Ayushi Sood, Joshua Peterson, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
April 17, 2019
When Monoclonal Gammopathy is of Renal Significance: A Case Study of Crystalglobulinemia From Chicago Multiple Myeloma Rounds
Brendan A Gilmore, Roger A Rodby, David Cimbaluk, et al.
PDA Journal of Pharmaceutical Science and Technology
|
October 23, 2014
PARENTERAL DRUG ASSOCIATION POINTS TO CONSIDER: Pharmaceutical Quality Metrics Updated September 2014
, Steve Mendivil, Joyce Bloomfield, et al.
American Journal of Hematology
|
April 21, 2020
A multi-institutional comparison of mitoxantrone, etoposide, and cytarabine vs high-dose cytarabine and mitoxantrone therapy for patients with relapsed or refractory acute myeloid leukemia
Sonia Christian, Saad Arain, Pritesh Patel, et al.
Leukemia & Lymphoma
|
October 26, 2017
A phase 1 trial of autologous stem cell transplantation conditioned with melphalan 200 mg/m<sup>2</sup> and total marrow irradiation (TMI) in patients with relapsed/refractory multiple myeloma
Pritesh Patel, Annie L Oh, Matthew Koshy, et al.
Haematologica
|
June 19, 2025
Intensified conditioning with high-dose total marrow irradiation and myeloablative chemotherapy reduces risk of relapse without increasing toxicity in allogeneic hematopoietic stem cell transplant for high-risk myeloid malignancies: a phase II study
Lucas Maahs, Ana Maria Avila, Matthew Koshy, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 20, 2014
Combination of linear accelerator-based intensity-modulated total marrow irradiation and myeloablative fludarabine/busulfan: a phase I study
Pritesh Patel, Bulent Aydogan, Matthew Koshy, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
April 11, 2025
Persistent opioid use is associated with a shorter myeloma survival
Karen Sweiss, Ana Maria Avila Rodriguez, John G Quigley, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 64) with videos related to
Sort By:
Page
of 7
Journal of Clinical Apheresis
|
May 28, 2021
Race/ethnicity and underlying disease influences hematopoietic stem/progenitor cell mobilization response: A single center experience
Chukwuemeka Uzoka, Li C Liu, Youngmin Park, et al.
Academic Radiology
|
May 3, 2022
A Clinically Optimal Protocol for the Imaging of Enteric Tubes: On the Basis of Radiologist Interpreted Diagnostic Utility and Radiation Dose Reduction
Wesley J Klejch, Emily L Marshall, Kayla F Blunt, et al.
Molecular Medicine (Cambridge, Mass.)
|
May 19, 2026
Gdf15 expression in thermogenic adipocytes regulates diet-induced weight gain in a sex-dependent manner
Jayashree Jena, Ayushi Sood, Joshua Peterson, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
April 17, 2019
When Monoclonal Gammopathy is of Renal Significance: A Case Study of Crystalglobulinemia From Chicago Multiple Myeloma Rounds
Brendan A Gilmore, Roger A Rodby, David Cimbaluk, et al.
PDA Journal of Pharmaceutical Science and Technology
|
October 23, 2014
PARENTERAL DRUG ASSOCIATION POINTS TO CONSIDER: Pharmaceutical Quality Metrics Updated September 2014
, Steve Mendivil, Joyce Bloomfield, et al.
American Journal of Hematology
|
April 21, 2020
A multi-institutional comparison of mitoxantrone, etoposide, and cytarabine vs high-dose cytarabine and mitoxantrone therapy for patients with relapsed or refractory acute myeloid leukemia
Sonia Christian, Saad Arain, Pritesh Patel, et al.
Leukemia & Lymphoma
|
October 26, 2017
A phase 1 trial of autologous stem cell transplantation conditioned with melphalan 200 mg/m<sup>2</sup> and total marrow irradiation (TMI) in patients with relapsed/refractory multiple myeloma
Pritesh Patel, Annie L Oh, Matthew Koshy, et al.
Haematologica
|
June 19, 2025
Intensified conditioning with high-dose total marrow irradiation and myeloablative chemotherapy reduces risk of relapse without increasing toxicity in allogeneic hematopoietic stem cell transplant for high-risk myeloid malignancies: a phase II study
Lucas Maahs, Ana Maria Avila, Matthew Koshy, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 20, 2014
Combination of linear accelerator-based intensity-modulated total marrow irradiation and myeloablative fludarabine/busulfan: a phase I study
Pritesh Patel, Bulent Aydogan, Matthew Koshy, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
April 11, 2025
Persistent opioid use is associated with a shorter myeloma survival
Karen Sweiss, Ana Maria Avila Rodriguez, John G Quigley, et al.
Page
of 7